Oral Administration of Heat-Treated Lactobacilli Modifies the Murine Microbiome and Reduces Citrobacter Induced Colitis

Frontiers in Microbiology

Volumn 11, Issue , 2020, Pages

  Warda, Alicja K ^a   de Almeida Bettio, Pedro H ^a   Hueston, Cara M ^a   Di Benedetto, Giulio ^a   Clooney, Adam G ^a   Hill, Colin ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Citrobacter; dead probiotics; inflammation; microbiome; pharmabiotics

Indexed keywords

ADR 159; BACTERIAL DNA; BUTYRIC ACID; CYTOKINE; DNA 16S; INTERLEUKIN 12P35; INTERLEUKIN 17F; ISOBUTYRIC ACID; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROBIOTIC AGENT; PROPIONIC ACID; RNA 16S; SHORT CHAIN FATTY ACID; VALERIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CITROBACTER; CITROBACTER RODENTIUM; CITROBACTER RODENTIUM INFECTION; CLOSTRIDIUM SENSU STRICTO; COLITIS; COLON; CONTROLLED STUDY; ENTEROBACTERIACEAE INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; ILEUM; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS FERMENTUM; MALE; METAGENOMICS; MICROBIAL BIOMASS; MOUSE; NONHUMAN; SMALL INTESTINE; TURICIBACTER; VIRUS LIKE AGENT;

EID: 85079484899     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2020.00069     Document Type: Article

References (75)

1. Alipour M., Lou Y., Zimmerman D., Bording-Jorgensen M. W., Sergi C., Liu J. J., et al. (2013). A balanced IL-1beta activity is required for host response to Citrobacter rodentium infection. PLoS One 8:e80656. 10.1371/journal.pone.0080656 24312491
2. Allard G., Ryan F. J., Jeffery I. B., Claesson M. J., (2015). SPINGO: a rapid species-classifier for microbial amplicon sequences. BMC Bioinformatics 16:324. 10.1186/s12859-015-0747-1 26450747
3. Behzadi P., Behzadi E., Ranjbar R., (2016). IL-12 family cytokines: general characteristics, pathogenic microorganisms, receptors, and signalling pathways. Acta Microbiol. Immunol. Hung. 63 1–25. 10.1556/030.63.2016.1.1 27020866
4. Belizario J. E., Faintuch J., Garay-Malpartida M., (2018). Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases. Mediators Inflamm. 2018:2037838. 10.1155/2018/2037838 30622429
5. Bello R. O., Chin V. K., Abd Rachman Isnadi M. F., Abd Majid R., Atmadini Abdullah M., Lee T. Y., et al. (2018). The role, involvement and function(s) of interleukin-35 and interleukin-37 in disease pathogenesis. Int. J. Mol. Sci. 19:E1149. 10.3390/ijms19041149 29641433
6. Bolger A. M., Lohse M., Usadel B., (2014). Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30 2114–2120. 10.1093/bioinformatics/btu170 24695404
7. Burokas A., Arboleya S., Moloney R. D., Peterson V. L., Murphy K., Clarke G., et al. (2017). Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol. Psychiatry 82 472–487. 10.1016/j.biopsych.2016.12.031 28242013
8. Callahan B. J., Mcmurdie P. J., Rosen M. J., Han A. W., Johnson A. J., Holmes S. P., (2016). DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13 581–583. 10.1038/nmeth.3869 27214047
9. Chassaing B., Srinivasan G., Delgado M. A., Young A. N., Gewirtz A. T., Vijay-Kumar M., (2012). Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One 7:e44328. 10.1371/journal.pone.0044328 22957064
10. Chen L., Deng H., Cui H., Fang J., Zuo Z., Deng J., et al. (2018). Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9 7204–7218. 10.18632/oncotarget.23208 29467962
11. Collins J. W., Chervaux C., Raymond B., Derrien M., Brazeilles R., Kosta A., et al. (2014a). Fermented dairy products modulate Citrobacter rodentium-induced colonic hyperplasia. J. Infect. Dis. 210 1029–1041. 10.1093/infdis/jiu205 24706936
12. Collins J. W., Keeney K. M., Crepin V. F., Rathinam V. A., Fitzgerald K. A., Finlay B. B., et al. (2014b). Citrobacter rodentium: infection, inflammation and the microbiota. Nat. Rev. Microbiol. 12 612–623. 10.1038/nrmicro3315 25088150
13. Crepin V. F., Collins J. W., Habibzay M., Frankel G., (2016). Citrobacter rodentium mouse model of bacterial infection. Nat. Protoc. 11 1851–1876. 10.1038/nprot.2016.100 27606775
14. Dann S. M., Spehlmann M. E., Hammond D. C., Iimura M., Hase K., Choi L. J., et al. (2008). IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens. J. Immunol. 180 6816–6826. 10.4049/jimmunol.180.10.6816 18453602
15. de Almada C. N., Almada C. N., Martinez R. C. R., Sant’ana A. S., (2016). Paraprobiotics: evidences on their ability to modify biological responses, inactivation methods and perspectives on their application in foods. Trends Food Sci. Technol. 58 96–114. 10.1016/j.tifs.2016.09.011
16. den Besten G., Van Eunen K., Groen A. K., Venema K., Reijngoud D. J., Bakker B. M., (2013). The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54 2325–2340. 10.1194/jlr.R036012 23821742
17. Dinan T. G., Cryan J. F., (2017). The microbiome-gut-brain axis in health and disease. Gastroenterol. Clin. North Am. 46 77–89. 10.1016/j.gtc.2016.09.007 28164854
18. Edgar R. C., Haas B. J., Clemente J. C., Quince C., Knight R., (2011). UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27 2194–2200. 10.1093/bioinformatics/btr381 21700674
19. Eftychi C., Schwarzer R., Vlantis K., Wachsmuth L., Basic M., Wagle P., et al. (2019). Temporally distinct functions of the cytokines IL-12 and IL-23 drive chronic colon inflammation in response to intestinal barrier impairment. Immunity 51 367–380.e4. 10.1016/j.immuni.2019.06.008 31350179
20. Ferrero-Miliani L., Nielsen O. H., Andersen P. S., Girardin S. E., (2007). Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin. Exp. Immunol. 147 227–235. 17223962
21. Gaffen S. L., (2009). Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9 556–567. 10.1038/nri2586 19575028
22. Giron F., Quigley E. M. M., (2018). Pharmabiotic manipulation of the microbiota in gastrointestinal disorders: a clinical perspective. J. Neurogastroenterol. Motil. 24 355–366. 10.5056/jnm18004 29684976
23. Grazziotin A. L., Koonin E. V., Kristensen D. M., (2017). Prokaryotic virus orthologous groups (pVOGs): a resource for comparative genomics and protein family annotation. Nucleic Acids Res. 45 D491–D498. 10.1093/nar/gkw975 27789703
24. Guerin E., Shkoporov A., Stockdale S. R., Clooney A. G., Ryan F. J., Sutton T. D. S., et al. (2018). Biology and taxonomy of crAss-like bacteriophages, the most abundant virus in the human gut. Cell Host Microbe 24 653–664.e6. 10.1016/j.chom.2018.10.002 30449316
25. Gupta R. S., Gao B., (2009). Phylogenomic analyses of clostridia and identification of novel protein signatures that are specific to the genus Clostridium sensu stricto (cluster I). Int. J. Syst. Evol. Microbiol. 59 285–294. 10.1099/ijs.0.001792-0 19196767
26. Hellemans J., Mortier G., De Paepe A., Speleman F., Vandesompele J., (2007). qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 8:R19. 17291332
27. Higgins L. M., Frankel G., Douce G., Dougan G., Macdonald T. T., (1999). Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect. Immun. 67 3031–3039. 10.1128/iai.67.6.3031-3039.1999 10338516
28. Hoffmann C., Hill D. A., Minkah N., Kirn T., Troy A., Artis D., et al. (2009). Community-wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep sequencing. Infect. Immun. 77 4668–4678. 10.1128/IAI.00493-09 19635824
29. Holder M. K., Peters N. V., Whylings J., Fields C. T., Gewirtz A. T., Chassaing B., et al. (2019). Dietary emulsifiers consumption alters anxiety-like and social-related behaviors in mice in a sex-dependent manner. Sci. Rep. 9:172. 10.1038/s41598-018-36890-3 30655577
30. Horie M., Miura T., Hirakata S., Hosoyama A., Sugino S., Umeno A., et al. (2017). Comparative analysis of the intestinal flora in type 2 diabetes and nondiabetic mice. Exp. Anim. 66 405–416. 10.1538/expanim.17-0021 28701620
31. Ishigame H., Kakuta S., Nagai T., Kadoki M., Nambu A., Komiyama Y., et al. (2009). Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30 108–119. 10.1016/j.immuni.2008.11.009 19144317
32. Jiminez J. A., Uwiera T. C., Abbott D. W., Uwiera R. R. E., Inglis G. D., (2017). Butyrate supplementation at high concentrations alters enteric bacterial communities and reduces intestinal inflammation in mice infected with Citrobacter rodentium. mSphere 2:e00243-17. 10.1128/mSphere.00243-17 28861518
33. Jiminez J. A., Uwiera T. C., Douglas Inglis G., Uwiera R. R., (2015). Animal models to study acute and chronic intestinal inflammation in mammals. Gut Pathog. 7:29.
34. Jones-Hall Y. L., Kozik A., Nakatsu C., (2015). Ablation of tumor necrosis factor is associated with decreased inflammation and alterations of the microbiota in a mouse model of inflammatory bowel disease. PLoS One 10:e0119441. 10.1371/journal.pone.0119441 25775453
35. Kaplanski G., (2018). Interleukin-18: biological properties and role in disease pathogenesis. Immunol. Rev. 281 138–153. 10.1111/imr.12616 29247988
36. Kelly J. R., Minuto C., Cryan J. F., Clarke G., Dinan T. G., (2017). Cross talk: the microbiota and neurodevelopmental disorders. Front. Neurosci. 11:490. 10.3389/fnins.2017.00490 28966571
37. Kim M., Ashida H., Ogawa M., Yoshikawa Y., Mimuro H., Sasakawa C., (2010). Bacterial interactions with the host epithelium. Cell Host Microbe 8 20–35. 10.1016/j.chom.2010.06.006 20638639
38. Kittana H., Quintero-Villegas M. I., Bindels L. B., Gomes-Neto J. C., Schmaltz R. J., Segura Munoz R. R., et al. (2018). Galactooligosaccharide supplementation provides protection against Citrobacter rodentium-induced colitis without limiting pathogen burden. Microbiology 164 154–162. 10.1099/mic.0.000593 29256851
39. Koroleva E. P., Halperin S., Gubernatorova E. O., Macho-Fernandez E., Spencer C. M., Tumanov A. V., (2015). Citrobacter rodentium-induced colitis: a robust model to study mucosal immune responses in the gut. J. Immunol. Methods 421 61–72. 10.1016/j.jim.2015.02.003 25702536
40. LeBlanc J. G., Chain F., Martin R., Bermudez-Humaran L. G., Courau S., Langella P., (2017). Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microb. Cell Fact. 16:79. 10.1186/s12934-017-0691-z 28482838
41. Leppkes M., Becker C., Ivanov I. I., Hirth S., Wirtz S., et al. (2009). RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 136 257–267. 10.1053/j.gastro.2008.10.018 18992745
42. Li J., Casanova J. L., Puel A., (2018). Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation. Mucosal Immunol. 11 581–589. 10.1038/mi.2017.97 29186107
43. Lin W. H., Yu B., Lin C. K., Hwang W. Z., Tsen H. Y., (2007). Immune effect of heat-killed multistrain of Lactobacillus acidophilus against Salmonella typhimurium invasion to mice. J. Appl. Microbiol. 102 22–31. 10.1111/j.1365-2672.2006.03073.x 17184316
44. Livak K. J., Schmittgen T. D., (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25 402–408. 10.1006/meth.2001.1262 11846609
45. Love M. I., Huber W., Anders S., (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15:550. 25516281
46. Lupp C., Robertson M. L., Wickham M. E., Sekirov I., Champion O. L., Gaynor E. C., et al. (2007). Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2 119–129. 10.1016/j.chom.2007.06.010 18005726
47. Mangan P. R., Harrington L. E., O’quinn D. B., Helms W. S., Bullard D. C., Elson C. O., et al. (2006). Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 231–234. 16648837
48. McMurdie P. J., Holmes S., (2013). phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 8:e61217. 10.1371/journal.pone.0061217 23630581
49. Mehta A. K., Gracias D. T., Croft M., (2018). TNF activity and T cells. Cytokine 101 14–18. 10.1016/j.cyto.2016.08.003 27531077
50. Mendes M. C. S., Paulino D. S., Brambilla S. R., Camargo J. A., Persinoti G. F., Carvalheira J. B. C., (2018). Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice. World J. Gastroenterol. 24 1995–2008. 10.3748/wjg.v24.i18.1995 29760543
51. Mondelaers S. U., Theofanous S. A., Florens M. V., Perna E., Aguilera-Lizarraga J., Boeckxstaens G. E., et al. (2016). Effect of genetic background and postinfectious stress on visceral sensitivity in Citrobacter rodentium-infected mice. Neurogastroenterol. Motil. 28 647–658. 10.1111/nmo.12759 26728091
52. Ngo V. L., Abo H., Maxim E., Harusato A., Geem D., Medina-Contreras O., et al. (2018). A cytokine network involving IL-36gamma, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage. Proc. Natl. Acad. Sci. U.S.A. 115 E5076–E5085. 10.1073/pnas.1718902115 29760082
53. Nurk S., Meleshko D., Korobeynikov A., Pevzner P. A., (2017). metaSPAdes: a new versatile metagenomic assembler. Genome Res. 27 824–834. 10.1101/gr.213959.116 28298430
54. Papaconstantinou H. T., Thomas J. S., (2007). Bacterial colitis. Clin. Colon Rectal Surg. 20 18–27. 10.1055/s-2007-970196 20011357
55. Pedersen H. K., Gudmundsdottir V., Nielsen H. B., Hyotylainen T., Nielsen T., Jensen B. A., et al. (2016). Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535 376–381. 10.1038/nature18646 27409811
56. Poretsky R., Rodriguez R. L., Luo C., Tsementzi D., Konstantinidis K. T., (2014). Strengths and limitations of 16S rRNA gene amplicon sequencing in revealing temporal microbial community dynamics. PLoS One 9:e93827. 10.1371/journal.pone.0093827 24714158
57. Roux S., Enault F., Hurwitz B. L., Sullivan M. B., (2015). VirSorter: mining viral signal from microbial genomic data. PeerJ 3:e985. 10.7717/peerj.985 26038737
58. Rubin D. C., Shaker A., Levin M. S., (2012). Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front. Immunol. 3:107. 10.3389/fimmu.2012.00107 22586430
59. Rutz S., Ouyang W., (2016). Regulation of interleukin-10 expression. Adv. Exp. Med. Biol. 941 89–116. 10.1007/978-94-024-0921-5_5 27734410
60. Shkoporov A. N., Ryan F. J., Draper L. A., Forde A., Stockdale S. R., Daly K. M., et al. (2018). Reproducible protocols for metagenomic analysis of human faecal phageomes. Microbiome 6:68. 10.1186/s40168-018-0446-z 29631623
61. Simmons C. P., Goncalves N. S., Ghaem-Maghami M., Bajaj-Elliott M., Clare S., Neves B., et al. (2002). Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma. J. Immunol. 168 1804–1812. 10.4049/jimmunol.168.4.1804 11823513
62. Tang C., Kakuta S., Shimizu K., Kadoki M., Kamiya T., Shimazu T., et al. (2018). Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing Treg cells through modification of the intestinal microbiota. Nat. Immunol. 19 755–765. 10.1038/s41590-018-0134-y 29915298
63. Tatusov R. L., Galperin M. Y., Natale D. A., Koonin E. V., (2000). The COG database: a tool for genome-scale analysis of protein functions and evolution. Nucleic Acids Res. 28 33–36. 10.1093/nar/28.1.33 10592175
64. Taverniti V., Guglielmetti S., (2011). The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr. 6 261–274. 10.1007/s12263-011-0218-x 21499799
65. Thakur B. K., Saha P., Banik G., Saha D. R., Grover S., Batish V. K., et al. (2016). Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response. Int. Immunopharmacol. 36 39–50. 10.1016/j.intimp.2016.03.033 27107798
66. Toyonaga T., Matsuura M., Mori K., Honzawa Y., Minami N., Yamada S., et al. (2016). Lipocalin 2 prevents intestinal inflammation by enhancing phagocytic bacterial clearance in macrophages. Sci. Rep. 6:35014. 10.1038/srep35014 27734904
67. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:Research0034. 12184808
68. Wang H., Shi P., Zuo L., Dong J., Zhao J., Liu Q., et al. (2016). Dietary non-digestible polysaccharides ameliorate intestinal epithelial barrier dysfunction in IL-10 knockout mice. J. Crohns Colitis 10 1076–1086. 10.1093/ecco-jcc/jjw065 26944415
69. Warda A. K., Rea K., Fitzgerald P., Hueston C., Gonzalez-Tortuero E., Dinan T. G., et al. (2018). Heat-killed lactobacilli alter both microbiota composition and behaviour. Behav. Brain Res. 362 213–223. 10.1016/j.bbr.2018.12.047 30597248
70. Weingarden A. R., Vaughn B. P., (2017). Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes 8 238–252. 10.1080/19490976.2017.1290757 28609251
71. Wiles S., Clare S., Harker J., Huett A., Young D., Dougan G., et al. (2004). Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell Microbiol. 6 963–972. 10.1111/j.1462-5822.2004.00414.x 15339271
72. Wilson B., Whelan K., (2017). Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders. J. Gastroenterol. Hepatol. 32(Suppl. 1), 64–68. 10.1111/jgh.13700 28244671
73. Zenewicz L. A., Flavell R. A., (2011). Recent advances in IL-22 biology. Int. Immunol. 23 159–163. 10.1093/intimm/dxr001 21393631
74. Zenewicz L. A., Yin X., Wang G., Elinav E., Hao L., Zhao L., et al. (2013). IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J. Immunol. 190 5306–5312. 10.4049/jimmunol.1300016 23585682
75. Zundler S., Neurath M. F., (2015). Interleukin-12: functional activities and implications for disease. Cytokine Growth Factor Rev. 26 559–568. 10.1016/j.cytogfr.2015.07.003 26182974